We are live on
!
Find out more
CytomX Therapeutics
CTMX
CTMX
121 hedge funds and large institutions have $614M invested in CytomX Therapeutics in 2025 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,607% more call options, than puts
Call options by funds: $6.14M | Put options by funds: $360K
90% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 20
56% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 25
40% more capital invested
Capital invested by funds: $438M → $614M (+$175M)
17% more funds holding
Funds holding: 103 → 121 (+18)
1.68% more ownership
Funds ownership: 83.33% → 85.02% (+1.7%)
Holders
121
Holders Change
+18
Holders Change %
+17.48%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
38
Increased
39
Reduced
25
Closed
20
Calls
$6.14M
Puts
$360K
Net Calls
+$5.78M
Net Calls Change
-$26K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$35.3M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$20.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$17.1M |
| 4 |
EP
Eversept Partners
New York
|
+$9.52M |
| 5 |
Financial Engines Advisors
Santa Clara,
California
|
+$9.3M |
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$35.3M |
| 2 |
O
OrbiMed
New York
|
-$18.8M |
| 3 |
RI
RTW Investments
New York
|
-$11M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$8.49M |
| 5 |
Renaissance Technologies
New York
|
-$8.12M |
